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Immunoblotting analysis was used to detect the microtubule-associated proteins present at different stages 
of rat brain development. Polyclonal antibodies were raised against the two main adult brain microtubule- 
associated proteins: MAP-2 (300 kDa) and TAU (6&70 kDa). Whatever the stage of development, anti- 
MAP-2 serum detected high molecular mass proteins and at immature stages a protein of 62 kDa. This 
protein which has previously been referred to as ‘young TAU slow’ is, therefore, immunologically related 
to MAP-2. The anti-TAU serum (but not the anti-MAP-2 serum) detected at immature stages of develop- 
ment a 48 kDa protein which also disappears at adulthood. This 48 kDa entity which has been referred 
to as ‘young TAU fast’ is progressively replaced by the closely spaced bands (60-70 kDa) of adult TAU 
proteins. The 62 and 48 kDa proteins appear therefore to be immunologically distinct and represent wo 
microtubule-associated proteins specific to the immature brain. 
Microtubule Microtubule-associatedprotein 
1. INTRODUCTION ing brain development and some MAPS are highly 
specific markers of the immature brain. 
Brain microtubules contain, at an adult stage, 
Brain DeveIopment 
several microtubule-associated proteins (MAPS): a 
group of > 200 kDa [1,2] and a group (TAU) of 
52-68 kDa [3.] One of the high molecular mass en- 
tities, MAP-2 (- 300 kDa), has been resolved into 
2 discrete peaks [1,4] whereas at early stages of 
brain developmlent MAP-2 is present as a single 
peak [4]. Similarly, at an adult stage of develop- 
ment, the TAU Ifraction is composed of several en- 
tities of 58-65 kDa [3] whereas at immature stages 
only 2 peaks are observed [5] which differ from 
adult TAU in several respects [5-81. We show here 
that the proteins detected at fetal, young post-natal 
stages of development and at adulthood react dif- 
ferently when tested with polyclonal antibodies 
raised against MAP-2 and TAU, respectively. At 
least 2 transitions in MAP composition occur dur- 
Abbreviations: MAPS, microtubule-associated pro- 
teins; MAP-l(2), microtubule-associated protein l(2); 
TAU, another microtubule-associated protein(s); Mes, 
2-(N-morpholino)ethanesulfonic acid 
2. MATERIALS AND METHODS 
2.1. Products 
GTP and Mes were from Boehringer. EDTA 
was from Prolabo. EGTA, leupeptin, phenyl- 
methylsulfonyl fluoride, trypsin inhibitor, benz- 
amidine, Tween 20 and bovine serum albumin 
(fraction V) were purchased from Sigma. Acryl- 
amide, bisacrylamide, SDS and nitrocellulose 
sheets were from Biorad. Anti-rabbit (Ig 1251)- 
labelled whole antibody from donkey (spec. act. 
5-20 Ci/g) was from Amersham. 
2.2. Preparation of brain extracts 
Total and heat-stable supernatants were prepared 
from rat brain. Brains were homogenized in 1 ml/g 
tissue of buffer A : 0.1 M Mes (pH 6.4) containing 
0.5 mM MgCl2, 1 mM EGTA, 0.1 mM EDTA, 1 
mM GTP, 1 mM 2-mercaptoethanol, 10 mM benz- 
amidine, 5 PM leupeptin, 25 mg/l trypsin inhibitor 
and 1.5 ml/l phenylmethylsulfonyl fluoride (50 
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mg/ml DMSO). The homogenate was incubated at 
4°C for 30 min and then centrifuged at 100000 x g 
for 60 min. The supernatant was incubated at 4°C 
for 60 min in the presence of 0.75 M NaCl and 2 
mM dithiothreitol. The preparation was immersed 
in boiling water for 5 min. After centrifugation 
(2OOOOxg, 30 min), the supernatant was dialyzed 
overnight at 4°C against buffer A. 
2.3. Preparation of the antigens and antisera 
Rat brain microtubules were purified by the 
temperature-dependent assembly-disassembly pro- 
cedure [9]. MAPS were prepared as in [lo]. TAU 
was obtained by electrophoresis of the MAPS on 
SDS-polyacrylamide slab gels. The same technique 
was applied to obtain MAP-2 prepared from calf 
brain. The bands containing TAU or MAP-2 were 
excised from the gel, minced and homogenized 
with a Potter Dounce in the presence of 2 ml 
physiological saline. 
Antiserum to TAU or MAP-2 was produced by 
injecting male ‘Fauve de Bourgogne’ rabbits sub- 
cutaneously with 75 ,ug of the corresponding an- 
tigen in complete Freund’s adjuvant. The rabbits 
were boosted 3 and 5 weeks after the first injec- 
tion. Blood was collected once a week from the 
third week. Preimmune sera were obtained from 
the same animals prior to immunization. 
2.4. Qualitative and quantitative gel 
electrophoresis 
Proteins were analyzed on a linear 4-15% 
polyacrylamide slab gel gradient in the presence of 
0.2% SDS as described in [6] with some modifica- 
tions. Electrophoresis was carried out overnight at 
a constant current of 13 mA per gel. A better 
separation of the high molecular mass proteins was 
obtained by a modification of the method of 
Laemmli [ 111, the separation gel containing 0.2 M 
Tris-HCl (pH 8.8) and 0.1% SDS. 
2.5. Electrophoretic transfer and immunological 
detection of proteins 
The procedure used for transfer of proteins 
from polyacrylamide gels was that of Towbin et al. 
[12] with several modifications. The proteins were 
transferred to nitrocellulose sheets at room 
temperature in the Biorad Trans Blot Cell at a con- 
stant current of 0.25 A for 3 h. The nitrocellulose 
blots were cut into several vertical strips and in- 
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cubated for 2 h at 50°C in 10 mM Tris-HCl (pH 
7.4), 0.9% NaCl containing 3% bovine serum 
albumin (buffer A). After washing with 10 mM 
Tris-HCl (pH 7.4), 0.9% NaCl and 0.05% Tween 
20 (buffer B), the blot was incubated at room 
temperature for 60 min with the respective an- 
tiserum diluted as required in buffer A. The 
nitrocellulose blot was then washed with agitation 
in buffer B for 90 min, changing the buffer (20 
ml/lane) every 15 min. The blot was incubated at 
room temperature overnight with 1251-labelled 
donkey anti-rabbit Ig diluted to lo6 cpm/ml buffer 
A containing 10% new born calf serum and 0.01% 
NaN3. The blot was washed in buffer B as de- 
scribed above and dried between 2 sheets of What- 
man 3 mM paper. The wet blot was then auto- 
radiographed on Kodak X-AR5 X-ray films. In all 
cases no significant band was detected when the 
nitrocellulose blot was incubated with the preim- 
mune serum. Following electrophoretic transfer 
the gels were stained with Coomassie blue to test 
the efficiency of the transfer. 
3. RESULTS AND DISCUSSION 
Polyclonal antibodies were raised against adult 
MAP-2 and adult TAU. The antisera obtained 
after 2-3 weeks immunization reacted essentially 
with the parent antigen (fig.1). In contrast, the an- 
tisera obtained after longer periods of immuniza- 
tion against TAU protein revealed not only the in- 
jected antigen but also other MAPS (see figs.2a 
and 3a). This suggests that several MAPS share an- 
tigenic determinants, probably those related to 
their common property of co-assembling with 
microtubules, to induce tubulin assembly (see [ 131) 
and/or to interact with the calmodulin-Ca2+ com- 
plex [14,15]. For instance, structural homology of 
MAP-l and MAP-2 has been demonstrated by 
peptide mapping analysis and immunoreactivity 
[16]. Fig.1 also shows that the anti-TAU serum 
revealed 3 bands whereas 4 were seen after 
Coomassie blue staining. The reasons for this dif- 
ference are unknown but it is possible that some 
diffusion of the 2 very closely spaced heaviest TAU 
bands occurs during the electrophoretic transfer. 
These antisera were used to characterize, by 
polyacrylamide gel electrophoresis and im- 
munoblotting, the MAPS present at various stages 
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Fig.1. Immunoblotting of adult rat brain MAPS. Heat- 
treated adult brain supernatants were analyzed by 
polyacrylamide gel electrophoresis and immunoblotting. 
Immunoblotting was performed with the anti-MAP-2 
(lane 1) and anti-TAU (lane 2) sera. Lane 0: Coomassie 
blue staining of total adult brain heat-stable MAPS. The 
positions of the molecular mass markers are those of the 
immunoblotting experiments. 
of brain development. Preimmune sera were also 
used as controls and gave negative results. Several 
brain preparations were analyzed: (i) total 105 xg 
supernatants from rat brain homogenates; (ii) 
heat-treated lo5 x g supernatants prepared as 
described to obtain heat-stable MAPS [lo] (heat 
denaturation results in the elimination of 90% of 
the brain soluble proteins with only some of the 
MAPS being lost during this treatment); (iii) 
microtubule obtained as in [9]; (iv) total heat- 
stable MAPS prepared as described [lo]. 
Whatever the 3-day-old preparation used the 
anti-TAU serum revealed a major component of 
48 kDa (fig.2a, lanes l-4). When using the anti- 
MAP-2 serum very little immunoreactivity was 
present at the level of this 48 kDa entity; in con- 
trast, the anti-MAP-2 serum revealed a narrow 
band of 62 kDa (fig.2b, lanes l-4), which was only 
slightly detected by the anti-TAU serum (fig.2a, 
lanes l-4). Thus, whatever the brain preparation 
used the 48 and 62 kDa components, which have 
been referred to as young TAU fast and young 
TAU slow [6] on the basis of their detection by 
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Fig.2. Immunoblotting of rat brain fetal and 3-day old 
MAPS. (a,b) Immunoblotting results obtained with dif- 
ferent 3-day-old brain preparations. Lanes 1, total 
10’ x g supernatant; lanes 2, heat-treated lo5 x g super- 
natant; lanes 3, microtubules; lanes 4, heat-stable 
MAPS. Immunoblotting was performed with the anti- 
TAU (a, lanes l-4) and anti-MAP-2 (b, lanes 1-4) sera. 
Heat-stable supernatants prepared from fetal brain (17 
days gestation) were also analyzed: immunoblotting was 
performed with the anti-TAU (c, lane 1) and anti- 
MAP-2 (c, lane 2) sera. The same amount of thermo- 
stable proteins (5 pg) was analyzed in (a) lane 2, (b) lane 
2 and (c) lanes 1 and 2. Lane 0: Coomassie blue staining 
of total 3-hay-old brain heat-stable MAPS. The positions 
of the molecular mass markers are those of the immuno- 
blotting experiments. 
Coomassie blue staining (fig.2, lane 0), appear to 
be immunologically distinct since they are 
preferentially detected by only 1 of the 2 antisera. 
The 62 kDa entity is antigenically more closely 
related to MAP-2 than to TAU although it has an 
apparent molecular mass similar to that of one of 
the slower bands of the adult TAU complex. In 
contrast, the 2 antisera both detected high 
molecular mass components (fig.2a,b). However, 
depending on the type of preparation and on the 
antiserum used, the profiles of these high 
molecular mass components markedly differ both 
qualitatively and quantitatively. Some bands are 
absent in the heat-treated preparations (fig.2a,b, 
lanes 2,4) suggesting that they correspond to heat- 
labile MAPS. For instance, with the lo5 xg super- 
natant (fig.2a, lane 1) and microtubule preparation 
(fig.2a, lane 3), a very heavy component remaining 
in the stacking gel was detected by the anti-TAU 
serum. This unidentified entity is thermolabile 
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since it is absent in the heat-treated preparations 
(fig.2a, lanes 2,4). 
Two bands of 62 and 48 kDa were also found at 
a fetal stage (17 days gestation). However, the 62 
kDa band reacted at this stage with both the anti- 
MAP-2 and anti-TAU sera (fig.2c) suggesting that 
the fetal MAP which migrates in this position is 
different from that present at day 3 after birth. In 
contrast, the 48 kDa component reacted only with 
the anti-TAU serum both at fetal and early post- 
natal stages. Fig.2 also shows that the concentra- 
tion of the 62 kDa component is higher at the fetal 
stage than 3 days after birth. 
Previous results [6] showed that the 2 entities 
detected in the TAU region at early stages of brain 
development progressively disappear from birth to 
adulthood. Fig.3 shows that the immunoblotting 
technique also revealed marked changes in the 
composition of MAPS during brain development. 
Heat-stable supernatants prepared at day 3,6,15 
and 35 after birth were analyzed by polyacrylamide 
gel electrophoresis using slightly modified condi- 
a b 
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Fig.3. Changes in MAP composition during rat brain 
development analyzed by immunoblotting. Heat-treated 
supernatants were prepared from 3,6,15 and 35-day-old 
brains and analyzed by polyacrylamide gel electro- 
phoresis according to Laemmli [11] except that the 
separation buffer contained 0.2 M Tris-HCl (pH 8.8) 
and 0.1% SDS. Immunoblotting was performed with the 
anti-TAU (fig.3a) and anti-MAP-2 (b) sera. Lane 1, 3 
days; lane 2,6 days; lane 3, 15 days; lane 4,35 days. The 
same amount of thermostable proteins (10 fig) was 
analyzed in each lane. 
tions which allowed a better resolution of the high 
molecular mass components. Under these condi- 
tions anti-TAU and anti-MAP-2 sera revealed at 
least 8 components of >200 kDa. In the 50-65 
kDa region the band revealed by the anti-TAU 
serum at young stages of development was re- 
solved into at least 2 peaks with none of them be- 
ing stained by the anti-MAP-2 serum (fig.3a). This 
heterogeneous peak is still present at day 6 and 15 
but clearly in lower proportion that at day 3. At 
day 35, 4-5 closely spaced bands characteristic of 
adult TAU were clearly revealed by the anti-TAU 
serum but not by the anti-MAP-2 one. In contrast, 
the anti-MAP-2 serum revealed the 62 kDa entity 
in the immature brain preparation but only small 
amounts of this component at adulthood (fig.3b). 
In conclusion: (i) at the fetal stage 2 MAPS are 
detected by Western blotting. One of them of 62 
kDa is revealed by both the anti-MAP-2 and anti- 
TAU sera whereas the other, of 48 kDa, is only 
detected by the anti-TAU serum. At day 3 and 6 
after birth the same bands are present but a 
marked change in immunoreactivity occurs since 
the 62 kDa band is poorly detected by the anti- 
TAU serum. This suggests that the 62 kDa bands 
present at the fetal stage and soon after birth are 
immunologically different proteins. Two transi- 
tions in the composition of the 50-65 kDa MAPS 
therefore seem to occur during brain development 
i.e. (a) from the fetal to the new born stage (b) 
before adulthood. (ii) Both the 62 and 48 kDa 
MAPS present in the immature brain are pro- 
gressively replaced by the adult TAU entities; in 
total brain extracts very small amounts of the 62 
kDa component are present at adulthood. (iii) At 
day 15 after birth the brain contains a mixture of 
the ‘young’ and ‘adult’ MAPS of 50-70 kDa. This 
timing in the post-natal transition in MAP com- 
position correlates well with the so called ‘critical 
period’ of brain development, i.e. with the period 
at which intensive neurite outgrowth occurs. The 
functional significance of the heterogeneity of 
MAPS seen at each stage of brain development and 
of the changes in MAP composition occurring dur- 
ing the construction of the neuronal network re- 
mains to be determined. Recent unpublished 
results obtained with primary cultures of astro- 
cytes and neurons suggest that such a heterogeneity 
is related, at least partially, to the presence of dif- 
ferent cell types, neuronal or glial, and to the 
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changes in cell populations occurring during brain 
maturation. Whatever the validity of these assump- 
tions, the minimal conclusion of this work is that 
some immunologically different MAPS are specific 












Murphy, D.B., Vallee, R.B. and Borisy, G.G. 
(1977) Biochemistry 16, 2598-2605. 
Sloboda, R.D., Rudolph, S.A., Rosenbaum, J.L. 
and Greengard, P. (1975) Proc. Natl. Acad. Sci. 
USA 72, 177-181. 
Cleveland, S.W., Hwo, H.Y. and Hirschner, M.W. 
(1977) J. Mol. Biol. 116, 207-225. 
Binder, L.I., Frankfurter, A., Kim, H., Caceres, 
A., Payne, M.R. and Rebhun, L.I. (1984) Proc. 
Natl. Acad. Sci. USA 81, 5613-5617. 
Mareck, A., Fellous, A., Francon, J. and Nunez, J. 







Francon, J., Lennon, A.M., Fellous, A., Mareck, 
A., Pierre, M. and Nunez, J. (1982) Eur. J. Bio- 
them. 129, 465-471. 
Ginzburg, I., Scherson, T., Giveon, D., Behar, L. 
and Littauer, U.Z. (1982) Proc. Natl. Acad. Sci. 
USA 79, 4892-4896. 
Drubin, D.G., Caput, D. and Kirschner, M.W. 
(1984) J. Cell Biol. 98, 1090-1097. 
Shelanski, M.L., Gaskin, F. and Cantor, R.C. 
(1973) Proc. Natl. Acad. Sci. USA 70, 765-768. 
Fellous, A., Francon, J., Lennon, A.M. and 
Nunez, J. (1977) J. Biochem. 78, 167-174. 
Laemmli, U.K. (1970) Nature 227, 680-685. 
Towbin, H., Staemelin, T. and Gordon, J.C. 
(1979) Proc. Natl. Acad. Sci. USA 76, 4350-4354. 
Dustin, P. (1984) in: Microtubules 2nd edn, 
Springer, Berlin. 
Lee, Y.C. and Wolff, J. (1984) J. Biol. Chem. 259, 
1226-1230. 
Erneux, C., Passareiro, H. and Nunez, J. (1984) 
FEBS Lett. 172, 315-320. 
Herrmann, H., Pytela, R., Dalton, J.M. and 
Wiche, 0. (1984) J. Biol. Chem. 259, 612-617. 
335 
